Medtronic Stent Patent Ruling Makes DES Vulnerable; Will Guidant Cut Deal?
This article was originally published in The Gray Sheet
Executive Summary
Medtronic will appeal a Delaware federal court patent infringement ruling against its Driver and S7 coronary stents and challenge the validity of Guidant's Lau patent, the firm says